Finds Whooping Cough Vaccine Effective, Safe for Teens and Adults
[Go to website to read full article- bfg]
of the American Medical Association announced today that a study to be
published in the June 22/29 issue found that a new vaccine against whooping
cough is effective in teens and adults...
Until recently, teens and adults
have been unable to be vaccinated with available pediatric whooping cough
vaccines due to safety concerns.
study suggested that some 11,000 to 12,000 cases of permanent
neurological damage take place annually in the U.S.A. alone, as a
result of DPT vaccination.
more shocking figure on the reaction to the DPT vaccine indicates that
1 in 100 children react with
convulsions or collapse or high-pitched screaming. One out
of 3 of these--that is, 1 in 300--will remain permanently damaged!
According to the testimonies of the Assistant Secretary of Health,
Edward Brandt, Jr. M.D., before the U.S. Senate Committee on May 3,
1985, every year 35,000 children suffer neurological reactions because
of this vaccine. 2 (Compare this figure with that of federal studies
in the late 1970s which concluded that some 50 children a year are
permanently brain damaged by the pertussis vaccine.)
estimates that only about
10% of adverse reactions are reported,  a figure
supported by two National Vaccine Information Center (NVIC)
...In 1934, more
than 265,000 cases were reported in the United States with nearly 8,000
deaths, mostly in children. In 2003, the number of deaths was 13.
Simply put, the vaccine is 100
times more deadly than the disease., the number of
vaccine-related deaths dwarfs the number of disease deaths, which have
been about 10 annually for recent years according to the CDC, and only
8 in 1993, the last peak-incidence year (
runs in 3-4 year cycles, though vaccination certainly doesn't).
programs in children have reduced the threat, but the infection rate is now
climbing rapidly among teens and adults.
While the whooping cough, or
pertussis, is less severe with age and often mistaken for bronchitis,
... Due to large-scale
misdiagnosis, some experts believe that between one and two
million U.S. adults and adolescents may now become infected annually.
pertussis is misdiagnosed as bronchitis?- bfg]
use of the new acellular vaccines has the potential to counter a
quadrupling of the pertussis
infection rate in teens and adults in the last three years.”
[In other words,
our current vaccines don't work very long if at all..... - bfg]
children’s pertussis vaccine, however,
caused severe injection site
reactions in adults.
they reacted with high-pitched screaming? - bfg] ...
Reacting to a
Japanese outbreak in the 1980s, pharmaceutical companies there (e.g. Takeda)
designed pertussis vaccines that were based not on entire cell bodies, but
instead on a few key proteins
on the surface of the bacteria (acellular or component vaccines) ...
Over the last 20
years, Pichichero has been one of few voices arguing nationally that
acellular vaccines were needed in the United States
after seeing severe reactions to
whole cell body pertussis vaccine in his own children.
Results of the
study indicated that the Tdap vaccine elicited robust immune responses in
adolescents and adults to pertussis, tetanus and diphtheria antigens.
Specific findings include:
For both Tdap
and Td, greater
than 94 percent and nearly 100 percent of participants had protective
antibody concentrations (≥0.1 IU/mL) against diphtheria and
tetanus, respectively. .....
response rates to the each of the four pertussis antigens ranged from
86 percent to 95 percent in
adolescents, and 83 percent to 94 percent in adults.